Related Experiment Video
Updated: Jul 11, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Evaluation of growth parameters in patients with thalassemia major
Seyed Hessamedin Nabavizadeh1, Amir Anushiravani, Saideh Haghbin
1Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran.
Insights
Children with thalassemia major experience significant growth failure, with a high percentage falling below the 5th percentile for weight, height, and arm circumference compared to healthy peers. Regular monitoring and treatment are crucial for managing this common genetic disorder.
Area of Science:
- Pediatrics
- Genetics
- Hematology
Background:
- Thalassemia major is a severe, common single-gene disorder causing hemolytic anemia, particularly prevalent in Iran.
- Growth failure is a significant complication if thalassemia major is not managed effectively.
- This study addresses the need for thorough investigation of growth parameters in affected children.
Purpose of the Study:
- To evaluate and compare the physical growth parameters of children with thalassemia major against a control group of healthy children.
- To identify and quantify growth deficits in thalassemic pediatric patients.
Main Methods:
- A cross-sectional, descriptive, and analytical study was conducted on 121 pediatric patients with thalassemia major receiving blood transfusion.
- Physical growth parameters including height, weight, sitting height, and arm circumference were assessed.
- Data were compared with age, sex, and socioeconomic status-matched healthy children.
Main Results:
- Significantly higher rates of children with thalassemia major were below the 5th percentile for weight (53.7% vs. 17.1%), height (66.9% vs. 17.1%), and mid-arm circumference (72.7% vs. 32.5%) compared to controls.
- Statistical analysis confirmed these differences (p < 0.0001 for weight).
Conclusions:
- Thalassemia major is associated with substantial growth retardation in affected children.
- Recommendations include regular follow-up appointments with precise intervals for blood transfusions and desferrioxamine (desferal) administration.
- Effective management is essential to mitigate growth failure complications.
Background:
Thalassemia major is a severe hemolytic anemia and the most common single gene abnormality. It is very common in Iran, and needs thorough investigation. If not treated properly, growth failure is one of the most important complications of this disease. This study was designed to evaluate the growth parameters in thalassemic children and compare the obtained data with normal children.
Materials And Methods:
This cross-sectional, descriptive, and analytical study was carried out on 121 thalassemic patients who received blood transfusion therapy in Yasuj, with respect to the physical growth parameters such as height, weight, sitting height and arm circumference. Collected data were compared with data obtained from normal children (chosen from the same sex, age and socioeconomic groups).
Results:
According to statistical analysis, the weight of 53.7% of thalassemic and 17.1% of non-thalassemic patients, with the same age group, was under the 5th percentile (p < 0.0001). Height and mid-arm circumference were 66.9 vs. 17.1% and 72.7 vs. 32.5% respectively, under the 5th percentile.
Conclusion:
Considering the growth retardation of thalassemic patients, we recommend regular follow-ups with precise intervals for blood transfusion and desferal injection.
Related Concept Videos
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
